Showing results (1-10 of 80) with videos related to
Sort By:
Pageof 8
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|November 10, 2005
Can Canada sustain paediatric phase I trials? A national survey of cancer relapse in childrenLoretta Lau, Sylvain Baruchel, Journal of Pediatric Hematology/Oncology|January 19, 2007
A strategy for controlling potential interactions between natural health products and chemotherapy: a review in pediatric oncologyDugald Seely, Diana Stempak, Sylvain BaruchelCancer Investigation|June 17, 2006
Metronomic dosing of chemotherapy: applications in pediatric oncologyDiana Stempak, Dugald Seely, Sylvain BaruchelTranslational Oncology|July 1, 2017
Oral Metronomic Topotecan Sensitizes Crizotinib Antitumor Activity in ALKF1174L Drug-Resistant Neuroblastoma Preclinical ModelsLibo Zhang, Bing Wu, Sylvain BaruchelJournal of Pediatric Hematology/Oncology|May 25, 2013
Current and future strategies for relapsed neuroblastoma: challenges on the road to precision therapyDaniel A Morgenstern, Sylvain Baruchel, Meredith S IrwinPharmacotherapy|January 14, 2003
Celecoxib in human milk: a case reportDavid C Knoppert, Diana Stempak, Sylvain Baruchel, et al.Expert Opinion on Drug Discovery|September 25, 2012
Preclinical models for pediatric solid tumor drug discovery: current trends, challenges and the scopes for improvementSushil Kumar, Reza Bayat Mokhtari, Herman Yeger, et al.Current Radiopharmaceuticals|December 16, 2017
Review: The Role of Radiolabeled DOTA-Conjugated Peptides for Imaging and Treatment of Childhood NeuroblastomaNatasha Alexander, Reza Vali, Hojjat Ahmadzadehfar, et al.Palliative & Supportive Care|April 6, 2006
Health-related quality of life and enrollment in phase 1 trials in children with incurable cancerMaru Barrera, Norma D'Agostino, Janet Gammon, et al.Clinical Pharmacology and Therapeutics|November 12, 2002
Single-dose and steady-state pharmacokinetics of celecoxib in childrenDiana Stempak, Janet Gammon, Julia Klein, et al.Pageof 8